(JKI) iShares Morningstar Mid-Cap - Ratings and Ratios

Exchange: NASDAQ • Country: USA • Currency: USD • Type: Etf • ISIN: US4642884062

JKI: Mid-Cap, Value, Stocks, ETF, Fund

The iShares Morningstar Mid-Cap Value ETF (NASDAQ:JKI) is designed to mirror the performance of the Morningstar US Mid Cap Broad Value Index, which comprises mid-cap US stocks exhibiting distinct value characteristics. By investing at least 90% of its assets in the underlying indexs securities or representative depositary receipts, the fund aims to replicate the indexs returns.

The Morningstar US Mid Cap Broad Value Index is constructed using a proprietary methodology that identifies mid-cap companies with value traits. This index provides a benchmark for the funds performance, allowing investors to tap into the mid-cap value segment of the US equity market.

Analyzing the funds characteristics, we can infer that it is well-suited for investors seeking exposure to mid-cap value stocks in the US market. With a focus on value investing, the fund is likely to hold stocks with relatively low price-to-earnings ratios, high dividend yields, or other characteristics that indicate undervaluation.

Using the available and , we can forecast the funds potential performance. Given the current price of $74.24, the SMA20 at $74.21, and the SMA50 at $72.56, we can infer a potential upward trend. If the fund continues to track the underlying index, we can expect the price to potentially break through the 52-week high of $81.02, driven by the underlying value characteristics of the constituent stocks. Conversely, a decline below the SMA50 could signal a correction. With an AUM of $704.31M USD, the fund has a substantial asset base, which can help to reduce tracking errors and enhance liquidity.

Based on the technical indicators, a potential trading strategy could involve buying the fund on a pullback to the SMA50 ($72.56) and holding it until it reaches the 52-week high ($81.02), with a stop-loss below the 52-week low ($65.10). This strategy would require continuous monitoring of the funds price action and adjustments to the stop-loss as needed.

Additional Sources for JKI ETF

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

JKI ETF Overview

Market Cap in USD 704m
Category Mid-Cap Value
TER 0.06%
IPO / Inception 2004-06-28

JKI ETF Ratings

Growth Rating -20.7
Fundamental -
Dividend Rating 40.0
Rel. Strength -6.27
Analysts -
Fair Price Momentum 66.94 USD
Fair Price DCF -

JKI Dividends

Dividend Yield 12m 2.00%
Yield on Cost 5y 1.25%
Annual Growth 5y 5.22%
Payout Consistency 63.9%
Payout Ratio %

JKI Growth Ratios

Growth Correlation 3m 49.4%
Growth Correlation 12m -4.1%
Growth Correlation 5y -6.7%
CAGR 5y -8.98%
CAGR/Max DD 5y -0.13
Sharpe Ratio 12m -0.62
Alpha -4.34
Beta 0.753
Volatility 15.17%
Current Volume 14.9k
Average Volume 20d 16.7k
What is the price of JKI shares?
As of June 25, 2025, the stock is trading at USD 75.04 with a total of 14,939 shares traded.
Over the past week, the price has changed by +1.24%, over one month by +0.67%, over three months by +0.36% and over the past year by +5.73%.
Is iShares Morningstar Mid-Cap a good stock to buy?
Neither. Based on ValueRay´s Analyses, iShares Morningstar Mid-Cap is currently (June 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of -20.67 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of JKI is around 66.94 USD . This means that JKI is currently overvalued and has a potential downside of -10.79%.
Is JKI a buy, sell or hold?
iShares Morningstar Mid-Cap has no consensus analysts rating.
What are the forecasts for JKI share price target?
According to our own proprietary Forecast Model, JKI iShares Morningstar Mid-Cap will be worth about 76.2 in June 2026. The stock is currently trading at 75.04. This means that the stock has a potential upside of +1.57%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 76.2 1.6%